Milind Deshpande
CIK 1378588 · Chief Executive Officer · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$260.6K
Companies
3
Total Filings
31
Lifetime Open-Market Net
-$4.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Director | 91,454 | $2.85 | $260.6K | $0 | 10 | 2025-06-16 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Chief Executive Officer | 2,500 | — | — | -$4.67M | 18 | 2018-02-13 |
| ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | EVP and CSO | — | $76.01 | — | $0 | 3 | 2008-12-17 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-08 | ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.